Login Register Cart 0
Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet Our Regional Editor

Author(s): Mohammad Amjad Kamal

Volume 19, Issue 9, 2020

Page: [643 - 645] Pages: 3

DOI: 10.2174/187152731909201119090650

Next »
[1]
Bibi N, Parveen Z, Nawaz MS, Kamal MA. In silico structure modeling and molecular docking analysis of phosphoribosyl pyrophosphate amidotransferase (PPAT) with antifolate inhibitors. Curr Cancer Drug Targets 2019; 19(5): 408-16.
[http://dx.doi.org/10.2174/1568009619666181127115015]
[2]
Peluso I, Palmery M, Yarla NS, Perry G, Kamal MA. From oxidative stress to ageing via lifestyle, nutraceuticals, polypharmacy, and neuropsychological factors. Oxid Med Cell Longev 2018; 20186352689
[3]
Alexiou A, Soursou G, Chatzichronis S, et al. Role of GTPases in the regulation of mitochondrial dynamics in Alzheimer’s disease and CNS-related disorders. Mol Neurobiol 2019; 56(6): 4530-8.
[4]
Wei W, Ahmad SS, Chi S, Xie Y, Kamal MA, Li J. From molecular mechanism to the etiology of sjogren syndrome. Curr Pharm Des 2018; 24(35): 4177-85.
[5]
Sheikh IA, Jiffri EH, Ashraf GM, Kamal MA. Structural insights into the camel milk lactoperoxidase: homology modeling and molecular dynamics simulation studies. J Mol Graph Model 2019; 86: 43-51.
[6]
Lakkakula BVKS, Farran B, Lakkakula S, et al. Small molecule tyrosine kinase inhibitors and pancreatic cancer-trials and troubles. Semin Cancer Biol 2019; 56: 149-67.
[7]
Sharma AK, Sharma VR, Gupta GK, Ashraf GM, Kamal MA. Advanced glycation end products (AGEs), glutathione and breast cancer: Factors, mechanism and therapeutic interventions. Curr Drug Metab 2018.
[8]
Sheikh IA, Yasir M, Khan I, et al. Lactoperoxidase immobilization on silver nanoparticles enhances its antimicrobial activity. J Dairy Res 2018; 85(4): 460-4.
[9]
Islam MT, Ali ES, Uddin SJ, et al. Phytol: a review of biomedical activities. Food Chem Toxicol 2018; 121: 82-94.
[10]
Jabir NR, Firoz CK, Bhushan A, Tabrez S, Kamal MA. The use of azoles containing natural products in cancer prevention and treatment: an overview. Anticancer Agents Med Chem 2018; 18(1): 6-14.
[11]
Rizvi SMD, Hussain T, Ahmed ABF, et al. Gold nanoparticles: a plausible tool to combat neurological bacterial infections in humans. Biomed Pharmacother 2018; 107: 7-18.
[12]
Sharma M, Pandey C, Sharma N, Kamal MA, Sayeed U, Akhtar S. Cancer nanotechnology - an excursion on drug delivery systems. Anticancer Agents Med Chem 2018; 18(15): 2078-92.
[13]
Sheikh IA, Jiffri EH, Ashraf GM, Kamal MA, Beg MA. Structural studies on inhibitory mechanisms of antibiotic, corticosteroid and catecholamine molecules on lactoperoxidase. Life Sci 2018; 207: 412-9.
[14]
Sharma N, Sharma M, Shakeel E, et al. Molecular interaction and computational analytical studies of pinocembrin for its antiangiogenic potential targeting VEGFR-2: a persuader of metastasis. Med Chem 2018; 14(6): 626-40.
[15]
Khan H. Marya, Amin S, Kamal MA, Patel S. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects. Biomed Pharmacother 2018; 101: 860-70.
[16]
Miya Shaik M, Tamargo IA, Abubakar MB, Kamal MA, Greig NH, Gan SH. The Role of microRNAs in Alzheimer’s disease and their therapeutic potentials. Genes 2018; 9(4): 174.
[17]
Azhar A, Ashraf GM, Zia Q, et al. Frontier view on nanotechnological strategies for neuro-therapy. Curr Drug Metab 2018; 19(7): 596-604.
[18]
Islam A, Kamal MA. Editorial: Current vision of systemic autoimmune diseases - from diagnosis to management. Endocr Metab Immune Disord Drug Targets 2018; 18(2): 96-7.
[19]
Khan H, Zafar M, Den-Haan H, Perez-Sanchez H, Kamal MA. In-silico studies of isolated phytoalkaloid against lipoxygenase: study based on possible correlation. Comb Chem High Throughput Screen 2018; 21(3): 215-21.
[20]
Khan H, Jawad M, Kamal MA, et al. Evidence and prospective of plant derived flavonoids as antiplatelet agents: strong candidates to be drugs of future. Food Chem Toxicol 2018; 119: 355-67.
[21]
Reale M, D’Angelo C, Costantini E, et al. Expression profiling of cytokine, cholinergic markers, and Amyloid-β deposition in the APPSWE/PS1dE9 mouse model of Alzheimer’s disease pathology. J Alzheimers Dis 2018; 62(1): 467-76.
[22]
Ahmad F, Siddiqui A, Kamal MA, Sohrab SS. Inhibition of neurogenesis by zika virus infection. CNS Neurol Disord Drug Targets 2018; 17(2): 78-86.
[23]
Islam MT, Ali ES, Uddin SJ, et al. Sousa JM, de Moura Dantas SMM, Rolim HML, de Carvalho Melo-Cavalcante AA, Mubarak MS, Yarla NS, Shilpi JA, Mishra SK, Atanasov AG, Kamal MA. Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Lett 2018; 420: 129-45.
[24]
Islam MA, Khandker SS, Alam F, Kamal MA, Gan SH. Genetic risk factors in thrombotic primary antiphospholipid syndrome: a systematic review with bioinformatic analyses. Autoimmun Rev 2018; 17(3): 226-43.
[25]
Iman K, Mirza MU, Mazhar N, Vanmeert M, Irshad I, Kamal MA. In silico structure-based identification of novel acetylcholinesterase inhibitors against Alzheimer’s disease. CNS Neurol Disord Drug Target 2018; 17(1): 54-68.
[26]
Khan H, Rengasamy KRR, Pervaiz A, Nabavi SM, Atanasov AG, Kamal MA. Plant-derived mPGES-1 inhibitors or suppressors: a new emerging trend in the search for small molecules to combat inflammation. Eur J Med Chem 2018; 153: 2-28.
[27]
Khan H, Khattak S, Mubarak MS, Bawazeer SS, Abu-Izneid T, Kamal MA. Antidepressant potential of peptides: new insights as future therapeutic. CNS Neurol Disord Drug Target 2018; 17(1): 9-13.
[28]
Jabir NR, Anwar K, Firoz CK, Oves M, Kamal MA, Tabrez S. An overview on the current status of cancer nanomedicines. Curr Med Res Opin 2018; 34(5): 911-21.

Rights & Permissions Print Cite
Article Metrics
14
© 2024 Bentham Science Publishers | Privacy Policy